These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8183178

  • 21. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
    Gonnelli S, Cepollaro C, Montomoli M, Gennari L, Montagnani A, Palmieri R, Gennari C.
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):55-61. PubMed ID: 9059558
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.
    Gennari C, Agnusdei D, Camporeale A.
    Osteoporos Int; 1993 Jan; 3 Suppl 1():208-10. PubMed ID: 8461563
    [No Abstract] [Full Text] [Related]

  • 24. Use of nasally administered salmon calcitonin in preventing bone loss.
    Christiansen C.
    Calcif Tissue Int; 1991 Jan; 49 Suppl 2():S14-5. PubMed ID: 1933614
    [Abstract] [Full Text] [Related]

  • 25. Intranasal calcitonin suppresses increased bone resorption during short-term immobilization: a double-blind study of the effects of intranasal calcitonin on biochemical parameters of bone turnover.
    van der Wiel HE, Lips P, Nauta J, Kwakkel G, Hazenberg G, Netelenbos JC, van der Vijgh WJ.
    J Bone Miner Res; 1993 Dec; 8(12):1459-65. PubMed ID: 8304047
    [Abstract] [Full Text] [Related]

  • 26. Nasal calcitonin for treatment of established osteoporosis.
    Overgaard K, Riis BJ, Christiansen C, Pødenphant J, Johansen JS.
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):435-42. PubMed ID: 2688995
    [Abstract] [Full Text] [Related]

  • 27. Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers.
    Nielsen NM, von der Recke P, Hansen MA, Overgaard K, Christiansen C.
    Calcif Tissue Int; 1994 Jul; 55(1):8-11. PubMed ID: 7922794
    [Abstract] [Full Text] [Related]

  • 28. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C.
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study.
    Ljunghall S, Gärdsell P, Johnell O, Larsson K, Lindh E, Obrant K, Sernbo I.
    Calcif Tissue Int; 1991 Jul; 49(1):17-9. PubMed ID: 1893291
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L, Gur A, Cevik R, Nas K, Sarac AJ.
    Maturitas; 2005 Jul 16; 51(3):246-53. PubMed ID: 15978968
    [Abstract] [Full Text] [Related]

  • 36. A double blind study of intranasal calcitonin for established postmenopausal osteoporosis.
    Kapetanos G, Symeonides PP, Dimitriou C, Karakatsanis K, Potoupnis M.
    Acta Orthop Scand Suppl; 1997 Oct 16; 275():108-11. PubMed ID: 9385282
    [Abstract] [Full Text] [Related]

  • 37. [Effectiveness of intranasal salmon calcitonin treatment in postmenopausal osteoporosis].
    Kopaliani M.
    Georgian Med News; 2005 Apr 16; (121):38-42. PubMed ID: 15908722
    [Abstract] [Full Text] [Related]

  • 38. Calcitonin and postmenopausal bone loss.
    Reginster JY, Deroisy R, Lecart MP, Sarlet N, Fontaine MA, Albert A, Franchimont P.
    Exp Gerontol; 1990 Apr 16; 25(3-4):349-56. PubMed ID: 2226670
    [Abstract] [Full Text] [Related]

  • 39. A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium.
    Reginster JY, Meurmans L, Deroisy R, Jupsin I, Biquet I, Albert A, Franchimont P.
    Eur J Clin Invest; 1994 Aug 16; 24(8):565-9. PubMed ID: 7982445
    [Abstract] [Full Text] [Related]

  • 40. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.
    J Clin Endocrinol Metab; 1999 Jul 16; 84(7):2390-7. PubMed ID: 10404809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.